Home/Filings/4/0001209191-14-055929
4//SEC Filing

Anacor Pharmaceuticals, Inc. 4

Accession 0001209191-14-055929

CIK 0001411158operating

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 5:43 PM ET

Size

5.4 KB

Accession

0001209191-14-055929

Insider Transaction Report

Form 4
Period: 2014-09-02
Plattner Jacob j
Senior VP Research
Transactions
  • Sale

    Common Stock

    2014-09-02$23.34/sh6,875$160,44485,850 total(indirect: See Footnote)
Footnotes (3)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2014.
  • [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $23.0975 to $23.53, inclusive.
  • [F3]These shares are held by Jacob & Jeanne Plattner Trust U/A 7/17/04, Jacob Plattner & Jeanne Plattner, Trustees.

Issuer

Anacor Pharmaceuticals, Inc.

CIK 0001411158

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001411158

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:43 PM ET
Size
5.4 KB